| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 09/28/2004 | US6797820 Succinate compounds, compositions and methods of use and preparation |
| 09/28/2004 | US6797716 Imidazonaphthyridines |
| 09/28/2004 | US6797713 1,4 substituted piperazines, 1,4 substituted piperidines, and 1-substituted,4-alkylidenyl piperidine compounds; dual acting molecules having both leukotriene inhibition properties |
| 09/28/2004 | US6797710 Cardiovascular disorders; serine protease inhibitor; administering by mouth; bioavailability |
| 09/28/2004 | US6797709 Sexual disorders |
| 09/28/2004 | US6797708 Enzyme inhibitors such as 4-(2-(1-benzhydryl-2-(2-((benzyl-sulfonyl)amino)ethyl)-5-chloro-1h-indol-3 -yl)ethoxy) benzoic acid, used as analgesics or antiinflammatory agents |
| 09/28/2004 | CA2461833A1 Process for the preparation of organic compounds containing a sulfinyl or sulfonyl group |
| 09/28/2004 | CA2299013C Neuropeptide y antagonists |
| 09/28/2004 | CA2224125C Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride |
| 09/28/2004 | CA2128312C Use of n-(pyridinyl)-1h-indol-1-amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders |
| 09/23/2004 | WO2004081005A1 Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto |
| 09/23/2004 | WO2004081000A1 Quinazoline derivatives |
| 09/23/2004 | WO2004080999A1 Pyrazole compounds useful in the treatment of inflammation |
| 09/23/2004 | WO2004080998A1 Imidazol-4-yl-ethynyl-pyridine derivatives |
| 09/23/2004 | WO2004080997A1 Process for the preparation of loratadine |
| 09/23/2004 | WO2004080982A1 Pyrazine compounds as transforming growth factor (tgf) inhibitors |
| 09/23/2004 | WO2004080981A1 Pyrimidin-2-one compounds and their use as dopamine d3 receptor ligands |
| 09/23/2004 | WO2004080980A1 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 09/23/2004 | WO2004080977A1 4-substituted-5-cyano-1h-pyrimidin-6-(thi)ones as gsk-3 inhibitors |
| 09/23/2004 | WO2004080976A1 Phthalazinone derivatives |
| 09/23/2004 | WO2004080975A1 Nitrogen-containing heterocycle derivative and organic electroluminescent element using the same |
| 09/23/2004 | WO2004080973A1 Fused tri and tetra-cyclic pyrazole kinase inhibitors |
| 09/23/2004 | WO2004080972A1 Pirazole modulators of atp-binding cassette transporters |
| 09/23/2004 | WO2004080971A1 Tetrahydroquinoline derivatives useful as serine protease inhibitors |
| 09/23/2004 | WO2004080970A1 Novel bicyclic aromatic compounds, the production and use thereof in the form of drugs |
| 09/23/2004 | WO2004080969A1 Quinolinone / benzoxazinone derivatives and uses thereof |
| 09/23/2004 | WO2004080968A1 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| 09/23/2004 | WO2004080964A1 Indole derivatives useful for the treatment of diseases |
| 09/23/2004 | WO2004080961A2 Crystalline and amorphous solids of pantoprazole and processes for their preparation |
| 09/23/2004 | WO2004080487A1 Preventive or remedy for teeth grinding |
| 09/23/2004 | WO2004080480A1 Pharmaceutical preparations comprising acid-stabilised insulin |
| 09/23/2004 | WO2004080463A1 Heterocyclic kinase inhibitors: methods of use and synthesis |
| 09/23/2004 | WO2004080461A2 Stable pharmaceutical compositions of desloratadine |
| 09/23/2004 | WO2004080423A2 7-amino- isoindolyl compounds amd their pharmaceutical uses |
| 09/23/2004 | WO2004072027A3 Chemical derivatives binding very specifically with g-quadruplex dna structures and use thereof as a specific anti-cancer agent |
| 09/23/2004 | WO2004052304A3 Antibacterial compounds having a (pyrrole carboxamide)-(benzamide)-(imidazole carboxamide) motif |
| 09/23/2004 | WO2004050613A3 2-substituted-3-propenamide derivatives and methods of using the same |
| 09/23/2004 | WO2004041258A3 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses |
| 09/23/2004 | WO2004030637A3 Treatment of obesity and other disorders associated with excessive food intake |
| 09/23/2004 | WO2003082268A3 Hemiasterlin derivatives and uses thereof in the treatment of cancer |
| 09/23/2004 | US20040186295 G protein-coupled receptors activators such as 2-[2-(3-chlorophenyl)-2H-tetrazol-5-yl]pyridine, used as analgesics, anxiolytic, antidepressants, and for prophylaxis of psychological disorders |
| 09/23/2004 | US20040186292 Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides |
| 09/23/2004 | US20040186290 transferase enzyme modulators such as 2-(6-Chloropyridin-3-yl)-3-cyclopentyl-N-thiazol-2-ylpropionamide, used for prophylaxis of hyperglycemia and diabetes |
| 09/23/2004 | US20040186288 3,5-Diamino-1,2,4-triazoles as kinase inhibitors |
| 09/23/2004 | US20040186159 used to treat glaucomatous optic neuropathy and/or lower and control intraocular pressure (IOP) associated with normal-tension glaucoma, ocular hypertension, and/or glaucoma in warm blooded animals, including man |
| 09/23/2004 | US20040186154 treating or preventing a hypercholesterolemia-related or an inflammation-related condition ; apical sodium co-dependent bile acid transport inhibitor and an amount of a cyclooxygenase-2 (COX-2) selective inhibitor or its prodrug; kits |
| 09/23/2004 | US20040186153 Pharmaceutical use of N-carbamoylazole derivatives |
| 09/23/2004 | US20040186148 E.g., 1-(pyrid-2-yl-so2-),2-((4-(isopropylphenyl)-so2-),5-(isopropoxy)benzene; antiinflammatory agents; immunomodulatory activity rheumatoid arthritis, asthma, allergy, psoriasis, Crohn's disease, systemic lupus erythematosus, multiple sclerosis, diabetes, cancer, glaucoma, osteoporosis, renal ischemia |
| 09/23/2004 | US20040186146 E.g., R-N-2-[4-(pyrrolidin-1'-yl)methylphenyl]propionyl-methanesulfonamide; inhibition of chemotaxis of neutrophils induced by interleukin-8; antiinflammatory agents; psoriasis, ulcerative cholitis, glomerular nephritis, acute respiratory insufficiency, idiopathic fibrosis, and rheumatoid arthritis |
| 09/23/2004 | US20040186145 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 09/23/2004 | US20040186141 Arthropodicidal anthranilamides |
| 09/23/2004 | US20040186140 Cyclic derivatives as modulators of chemokine receptor activity |
| 09/23/2004 | US20040186139 Process for preparation of crystalline form-1 of pantoprazole sodium sesquihydrate |
| 09/23/2004 | US20040186135 Substituted piperidine compounds |
| 09/23/2004 | US20040186134 Inhibitors of Factor Xa are useful as anticoagulants in the treatment of cardiovascular disorders associated with thromboses; e.g., 1,1-dimethylethyl 1-[1-(-2-(-3-[2-(5-Chloro-thiophen-2-yl)-ethenesulfonylamino]-2-oxo-piperidin-1-yl)-acetyl)-pyrrolidin-2- yl-methyl]-pyrrolidin-3-yl}-methyl-carbamate |
| 09/23/2004 | US20040186133 preferably antagonists used in the therapeutic and/or preventive treatment of disfunctions of the heart, kidney, respiratory system, central nervous system |
| 09/23/2004 | US20040186132 Steroid receptor modulator compounds and methods |
| 09/23/2004 | US20040186129 2-Aroylimidazole compounds for treating cancer |
| 09/23/2004 | US20040186125 E.g , 3-cyclohexyl-2-furan-3-yl-1Hindole-5-carboxylic acid; hepatitis C viricides that target RNA dependent RNA polymerases (Ns5B) in mammals, an enzyme essential to viral replication; used in conjunction with an mmunomodulatory agent, such as beta -, delta - gamma -, and omega -interferon |
| 09/23/2004 | US20040186123 such as 2[(Benzyloxy)methyl]-8-methyl-2,3-dihydro[1,4]dioxino[2,3-f]quinoline; serotonin receptor antagonists for treatment of depression, obsessive compulsive disorders, panic disorder, generalized anxiety disorder, social anxiety disorders, sexual dysfunction, and eating disorders |
| 09/23/2004 | US20040186119 glycogen synthase kinase (GSK-3) inhibitors; for treatment of diabetes and alzheimer's disease |
| 09/23/2004 | US20040186118 Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 09/23/2004 | US20040186116 such as 2-(7-acetylamino-1-furano-2-ylmethyl-2,4-dioxo-1,4-dihydro-2H-quinazolin-3-yl)-succinic acid; for treatment of autoimmune diseases, proliferative diseases, angiogenic disorders, and/or cancers; catheters, prosthetics |
| 09/23/2004 | US20040186114 Cytokine inhibitors |
| 09/23/2004 | US20040186113 Heterocyclic amines for the treatment of conditions associated with gsk-3 |
| 09/23/2004 | US20040186111 Therapeutic agents useful for treating pain |
| 09/23/2004 | US20040186110 Nitrogenous heterocylic compounds |
| 09/23/2004 | US20040186102 such as {4-Chloro-3-[2-(3,4-dihydro-1H-isoquinolin-2-yl)ethoxy]phenyl}-(2-methylquinolin-4-yl)amine for treatment of cardiovascular disorders, kidney disorders, pain and inflammation |
| 09/23/2004 | US20040186099 Novel heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| 09/23/2004 | US20040186098 Method for preventing and treating hearing loss using sensorineurotrophic compounds |
| 09/23/2004 | US20040186097 such as N-phenyl-3-[[4-(phenylmethyl)-1-piperidinyl]methyl]-1-piperidinecarboxamide for prevention of asthma and allergies |
| 09/23/2004 | US20040186092 Tertiary carbocyclic amides such as 1-(3-Piperazin-1-yl-benzyl)-3,4-dihydro-1H-quinolin-2-one, used as serotonin receptor antagonists for prophylaxis of nervous system disorders and gastrointestinal disorders |
| 09/23/2004 | US20040186091 Triazole compounds useful in therapy |
| 09/23/2004 | US20040186088 Mercapto-cycloalkyl or heterocyclyl ring-sulfonyl-aryl or heteroaryl derivatives; preventing the cleavage Of tumor necrosis factor- alpha from cell membranes in mammal; treating autoimmune diseases, inflammation, inflammatory bowel disease, Crohn's disease, asthma, sepsis and septic shock |
| 09/23/2004 | US20040186080 Beta 2-adrenergic receptor agonists |
| 09/23/2004 | US20040186078 Substituted N'-(arylcarbonyl)-benzhydrazides, N'-(arylcarbonyl)-benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 09/23/2004 | US20040185352 Photothermographic element comprising improved base precursors and methods for their use |
| 09/23/2004 | US20040185299 Tertiary diamines containing heterocyclic groups and their use in organic electroluminescent devices |
| 09/23/2004 | DE10311065A1 New 1-(cyclic amino-alkyl)-pyrimidin-2(1H)-one derivatives, are selective dopamine D3 receptor ligands useful for treating CNS disorders, especially schizophrenia or depression |
| 09/23/2004 | DE10310278A1 New N-(benzazinyl)-(hetero)aralkylamine derivatives, are inhibitors of factor Xa and/or related serine proteases, useful e.g. as antithrombotic agents and intermediates |
| 09/23/2004 | CA2518999A1 Crystalline and amorphous solids of pantoprazole and processes for their preparation |
| 09/23/2004 | CA2518584A1 7-amino- isoindolyl compounds and their pharmaceutical uses |
| 09/23/2004 | CA2518403A1 Quinolinone/benzoxazinone derivatives and uses thereof |
| 09/23/2004 | CA2518398A1 Heterocyclic kinase inhibitors: methods of use and synthesis |
| 09/23/2004 | CA2518194A1 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| 09/23/2004 | CA2517885A1 Fused tri and tetra-cyclic pyrazole kinase inhibitors |
| 09/23/2004 | CA2517720A1 Pyrazine compounds as transforming growth factor (tgf) inhibitors |
| 09/23/2004 | CA2517569A1 Indole derivatives useful for the treatment of diseases |
| 09/22/2004 | EP1460073A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 09/22/2004 | EP1460070A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 09/22/2004 | EP1460069A1 Substituted cyclohexyl and piperidinyl derivatives as melanocortin-4 receptor modulators |
| 09/22/2004 | EP1460066A1 Piperazine compounds |
| 09/22/2004 | EP1460065A1 Processes for production of cyclic diamine compounds or salts thereof |
| 09/22/2004 | EP1460064A1 Indole-2-carboxamide derivatives useful as beta-2 agonists |
| 09/22/2004 | EP1460062A1 Nitrogenous cyclic ketone derivative, process for producing the same, and use |
| 09/22/2004 | EP1458718A1 Quinolinones as prostaglandin receptor ligands |
| 09/22/2004 | EP1458714A1 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives |
| 09/22/2004 | EP1458713A1 Indolinone derivatives useful as protein kinase inhibitors |
| 09/22/2004 | EP1458712A2 Novel compounds |
| 09/22/2004 | EP1458710A1 Heteroaryl substituted pyrrole modulators of metabotropic glutamate receptor-5 |